Acquisitions, biotechs and strategic updates

NASA is backing this company in a BIG way                                                                                                                                                                                                                                                                                                                                                                                                                 September 19, 2024 *together with Colonial Metals Group Good day, 360! Here are some of our top movers today. And don’t forget to join us in [Market Masters]( - the hottest trading room around 🔥. Be the best prepared trader on the Street! FOCUS LIST🔎 SGN - Up over 100% in the pre-market after signing binding term sheet to acquire majority equity interest in high growth sports gaming technology company Swifty Global GLMD - Up over 30% in pre after announcing an expansion of its activities to cancer and major cardiometabolic diseases ACHL - Up over 30% in pre after announcing strategic update *together with Colonial Metals Group No confidence in the Market? [Download THIS](. Buffett's $277 billion vote of no confidence in the stock market is a warning to anyone with a 401(k) or IRA. Protect yourself while you still can. Get your hands on this: Disclaimer: Colonial Metals Group does not provide investment, legal, retirement planning, or tax advice. Individuals should consult with their investment, legal or tax professionals for such services. HOTLIST🔥 SGN - Up over 100% in the pre-market after signing binding term sheet to acquire majority equity interest in high growth sports gaming technology company Swifty Global Signing Day Sports Inc. (SGN) operates a sports recruitment platform in the United States. The company offers Signing Day Sports, a sports recruitment platform that helps athletes get discovered and recruited by coaches and recruiters for various sports In the pre-market this morning, the [company announced]( the signing of a binding term sheet to acquire 95-99% of the issued and outstanding shares of Dear Cashmere Group Holding Company, doing business as Swifty Global (“Swifty”), a global sports and casino technologies company. The acquisition is expected to be the first transaction of its newly initiated growth strategy to buy and build companies in the sports and casino technology industry and other synergistic companies.  The transaction is structured as an all equity deal meaning that Signing Day Sports will acquire such percentage of Swifty through the issuance of its securities to the controlling stockholders of Swifty. Signing Day Sports is not required to make any cash payment to Swifty in connection with the acquisition of the Swifty equity securities. The stock traded up over 100% in the pre-market in reaction to the news. The first target for bulls is the pre-market high at $0.3270. Beyond that, $0.36, $0.40, $0.45 and $0.50 come into play. Below $0.3270, targets to the downside are $0.26, $0.24, $0.22, $0.20, $0.18, $0.15 and then a gap fill at $0.1299. GLMD - Up over 30% in pre after announcing an expansion of its activities to cancer and major cardiometabolic diseases Galmed Pharmaceuticals Ltd. (GLMD) is a biopharmaceutical company that focuses on the development of therapeutics for the treatment of liver diseases. In the pre-market this morning, the [company announced]( that based on the recently published results from the Open-Label part of its Phase 3 NASH study, new scientific publications on the role of SCD1 as a critical metabolic signaling hub as well as an extended cash runway, it plans to broaden its drug development activities. The planned expansion consists of two additional programs over the next two years. One program aims to identify novel Aramchol-based drug combinations to overcome resistance to standard-of-care oncological treatments for patients with advanced colorectal and hepatic cancers. Another program aims to unravel new mechanisms of action that will allow the development of a novel Aramchol-based drug combination targeting cardiac fibrosis, or scarring of the heart, which occurs in many cardiovascular diseases that can lead to heart dysfunction and failure. The Company plans on releasing new data from in-vitro and ex-vivo studies in these programs during the fourth quarter of 2024. The stock traded up over 30% in the pre-market in reaction to the news. The first target to the upside is prior resistance at $11. Above that $12 and $12.65 come into play. Beyond that, $15 and $20 come into play. Below $11, targets to the downside are $10, $9, $8, $7 and then a gap fill at $6.90. *together with Colonial Metals Group Take it from Larry Kudlow… Disclaimer: Colonial Metals Group does not provide investment, legal, retirement planning, or tax advice. Individuals should consult with their investment, legal or tax professionals for such services. [Claim Your Free 2024 Gold Guide HERE]( ACHL - Up over 30% in pre after announcing strategic update Achilles Therapeutics plc (ACHL) is a biopharmaceutical company that develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. In the pre-market this morning, the [company announced]( the discontinuation of development of TIL-based cNeT therapy. The Company will refocus its strategy to explore further engagement with third parties who are developing alternative modalities to target clonal neoantigens for the treatment of cancers The company stated it had a cash position of $95.1 million as of June 30, 2024 and had engaged BofA Securities to provide strategic financial advice. The stock traded up over 30% in the pre-market in reaction to the news.    The first target for bulls is the pre-market high at $1.08. Beyond that, $1.15, $1.30, $1.50 and $1.75 come into play. Below $1.08, targets to the downside are $1, $0.95, $0.90, $0.85, $0.80 and then a gap fill at $0.71. MARKET NEWS 📰 P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( *Sponsored content: We’re a proud affiliate for Colonial Metals Group, meaning if you click a link for a product or service, we may earn a commission at no extra cost to you. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America [Terms of Service](